Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Turek

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Gynecologic Oncology|June 1, 1997
The frequency of human papillomavirus detection in postmenopausal women on hormone replacement therapyE M Smith, S R Johnson, E J Figuerres, et al.
The New Biologist|May 1, 1990
Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modulesT P Cripe, A Alderborn, R D Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2008
Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?Elaine M Smith, Linda M Rubenstein, Justine M Ritchie, et al.
Virology|October 3, 2002
Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomesDaniel L Sprague, Stacia L Phillips, Calista J Mitchell, et al.
Journal of Virology|May 22, 2009
Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in cultureMichael J Lace, Christina Isacson, James R Anson, et al.
Journal of Virology|September 11, 2009
Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVsMichael J Lace, James R Anson, Aloysius J Klingelhutz, et al.
Cancer Detection and Prevention|January 1, 1991
The association between pregnancy and human papilloma virus prevalenceE M Smith, S R Johnson, D Jiang, et al.
Journal of Virology|December 3, 2010
Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancersMichael J Lace, James R Anson, Jens P Klussmann, et al.
Journal of the National Cancer Institute|March 18, 2004
Human papillomavirus in oral exfoliated cells and risk of head and neck cancerElaine M Smith, Justine M Ritchie, Kurt F Summersgill, et al.
Carcinogenesis|June 23, 2009
Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1Michael J Lace, James R Anson, Aloysius J Klingelhutz, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Gynecologic Oncology|June 1, 1997
The frequency of human papillomavirus detection in postmenopausal women on hormone replacement therapyE M Smith, S R Johnson, E J Figuerres, et al.
The New Biologist|May 1, 1990
Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modulesT P Cripe, A Alderborn, R D Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2008
Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?Elaine M Smith, Linda M Rubenstein, Justine M Ritchie, et al.
Virology|October 3, 2002
Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomesDaniel L Sprague, Stacia L Phillips, Calista J Mitchell, et al.
Journal of Virology|May 22, 2009
Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in cultureMichael J Lace, Christina Isacson, James R Anson, et al.
Journal of Virology|September 11, 2009
Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVsMichael J Lace, James R Anson, Aloysius J Klingelhutz, et al.
Cancer Detection and Prevention|January 1, 1991
The association between pregnancy and human papilloma virus prevalenceE M Smith, S R Johnson, D Jiang, et al.
Journal of Virology|December 3, 2010
Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancersMichael J Lace, James R Anson, Jens P Klussmann, et al.
Journal of the National Cancer Institute|March 18, 2004
Human papillomavirus in oral exfoliated cells and risk of head and neck cancerElaine M Smith, Justine M Ritchie, Kurt F Summersgill, et al.
Carcinogenesis|June 23, 2009
Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1Michael J Lace, James R Anson, Aloysius J Klingelhutz, et al.
Pageof 9